TY - JOUR
KW - Adult
KW - Analgesics, Opioid/economics/therapeutic use
KW - Australia
KW - Buprenorphine, Naloxone Drug Combination/administration & dosage/economics/therapeutic use
KW - Cost-Benefit Analysis
KW - Female
KW - Heroin Dependence/drug therapy/economics
KW - Humans
KW - Male
KW - Middle Aged
KW - Narcotic Antagonists/economics/therapeutic use
KW - Treatment Outcome
KW - Waiting Lists
KW - buprenorphine
KW - Controlled clinical trial
KW - Crime
KW - heroin dependence
AU - Adrian J. Dunlop
AU - Amanda L. Brown
AU - Christopher Oldmeadow
AU - Anthony Harris
AU - Anthony Gill
AU - Craig Sadler
AU - Karen Ribbons
AU - John Attia
AU - Daniel Barker
AU - Peter Ghijben
AU - Jennifer Hinman
AU - Melissa Jackson
AU - James Bell
AU - Nicholas Lintzeris
A1 - 
AD - Drug and Alcohol Clinical Services, Hunter New England Local Health District, Newcastle, NSW, Australia; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Centre for Brain and Mental Health, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia. Electronic address: Adrian.Dunlop@hnehealth.nsw.gov.au.; Drug and Alcohol Clinical Services, Hunter New England Local Health District, Newcastle, NSW, Australia; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Centre for Brain and Mental Health, University of Newcastle and Hunter Medical Research Institute, Newcastle, NSW, Australia. Electronic address: Amanda.Brown@hnehealth.nsw.gov.au.; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Clinical Research Design, IT and Statistical Support (CRepsilonDITSS) Unit, Hunter Medical Research Institute, Newcastle, NSW, Australia. Electronic address: Christopher.Oldmeadow@hmri.org.au.; Centre for Health Economics, Monash University, Clayton, Victoria, Australia. Electronic address: Anthony.Harris@monash.edu.; Drug and Alcohol Clinical Services, Hunter New England Local Health District, Newcastle, NSW, Australia; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia. Electronic address: anthony.gill@svha.org.au.; Drug and Alcohol Clinical Services, Hunter New England Local Health District, Newcastle, NSW, Australia; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Alcohol and Drug Unit, Calvary Mater Newcastle, Waratah, NSW, Australia. Electronic address: Craig.Sadler@calvarymater.org.au.; Drug and Alcohol Clinical Services, Hunter New England Local Health District, Newcastle, NSW, Australia. Electronic address: Karen.Ribbons@hnehealth.nsw.gov.au.; School of Medicine and Public Health, University of Newcastle, Callaghan, NSW, Australia; Clinica(TRUNCATED)
BT - Drug and alcohol dependence
C5 - Education & Workforce; Financing & Sustainability; Opioids & Substance Use
CY - Ireland
DO - 10.1016/j.drugalcdep.2017.01.016
JF - Drug and alcohol dependence
LA - eng
M1 - Journal Article
PB - . Published by Elsevier B.V
PP - Ireland
PY - 2017
SN - 1879-0046; 0376-8716
SP - 181
EP - 191
EP - 
T1 - Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial
T2 - Drug and alcohol dependence
TI - Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial
U1 - Education & Workforce; Financing & Sustainability; Opioids & Substance Use
U2 - 28371689
U3 - 10.1016/j.drugalcdep.2017.01.016
VL - 174
VO - 1879-0046; 0376-8716
Y1 - 2017
Y2 - May 1
ER -